Skip to main content

Chronopharmacology in Drug Development

  • Living reference work entry
  • First Online:
Drug Discovery and Evaluation: Methods in Clinical Pharmacology
  • 472 Accesses

Abstract

The human body is highly organized in time and most functions display significant daily [circadian] and seasonal rhythms. Gene expression in the brain as well in the peripheral tissues has been convincingly demonstrated to be circadian phase dependent for many genes. In addition, seasonal gene expression – with inverse rhythms in the Northern and Southern Hemisphere – has been evidenced as well. Taking into account these rhythmic changes in the body, it is conceivable that also the pharmacokinetics and/or the pharmacodynamics can be rhythmic in experimental animals as well in humans. In this review chronopharmacological findings are compiled demonstrating to what an extent rhythmic changes in the composition of the body in health and disease can contribute to variations in time-dependent drug treatments. The results of clinical chronopharmacological studies in hypertension, asthma, and ulcer disease and treatment of antihyperlipidemia are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References and Further Reading

  • Albrecht U (2012) Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 74(2):246–260. https://doi.org/10.1016/j.neuron.2012.04.006

    Article  CAS  PubMed  Google Scholar 

  • Allwinn R et al (2009) Arzneiverordnungen. In: Arzneimittelkommission, der, deutschen, Ärzteschaft (eds). 22 edn. Medizinische Medien Informations GmbH, Neu Isenburg

    Google Scholar 

  • Aschoff J (1947) Einige allgemeine Gesetzmäßigkeiten physikalischer Temperaturregulation. Pflügers Arch 249:125–136

    Article  CAS  Google Scholar 

  • Bruguerolle B, Bouvenot G, Bartolin R, Manolis J (1988) Chronopharmacocinetique de la digoxine chez le sujet de plus de soixante-dix ans. Therapie 43:251–253

    CAS  PubMed  Google Scholar 

  • Chen CY et al (2016) Effects of aging on circadian patterns of gene expression in the human prefrontal cortex. Proc Natl Acad Sci U S A 113(1):206–211. https://doi.org/10.1073/pnas.1508249112

    Article  CAS  PubMed  Google Scholar 

  • Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (1996) Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol 36:604–609

    Article  CAS  PubMed  Google Scholar 

  • Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA (2012) The human circadian metabolome. Proc Natl Acad Sci U S A 109(7):2625–2629. https://doi.org/10.1073/pnas.1114410109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dopico XC et al (2015) Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun 6:7000. https://doi.org/10.1038/ncomms8000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fukuda M et al (2008) Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens 26(3):583–588

    Article  CAS  PubMed  Google Scholar 

  • Goo RH, Moore JG, Greenberg E, Alazraki NP (1987) Circadian variation in gastric emptying of meals in humans. Gastroenterology 93:515–518

    Article  CAS  PubMed  Google Scholar 

  • Hermida RC et al (2003) Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 42(3):283–290

    Article  CAS  PubMed  Google Scholar 

  • Hermida RC, Ayala DE, Fernandez JR, Calvo C (2007a) Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50(4):715–722

    Article  CAS  PubMed  Google Scholar 

  • Hermida RC, Ayala DE, Smolensky MH, Portaluppi F (2007b) Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation. Expert Rev Cardiovasc Ther 5(3):463–475

    Article  PubMed  Google Scholar 

  • Hla KK, Latham AN, Henry JA (1992) Influence of time of administration on verapamil pharmacokinetics. Clin Pharmacol Ther 51(4):366–370

    Article  CAS  PubMed  Google Scholar 

  • Illingworth DR (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40:338–343

    Article  CAS  PubMed  Google Scholar 

  • Jespersen CM, Frederiksen M, Hansen JF, Klitgaard NA, Sorum C (1989) Circadian variation in the pharmacokinetics of verapamil. Eur J Clin Pharmacol 37(6):613–615

    CAS  PubMed  Google Scholar 

  • Koopmans R, Oosterhuis B, Karemaker JM, Wemer J, van Boxtel CJ (1993) The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. Eur J Clin Pharmacol 44:171–176.

    Article  CAS  PubMed  Google Scholar 

  • Konopka RJ, Benzer S (1971) Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci U S A 68(9):2112–2116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Langner B, Lemmer B (1988) Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 33:619–624

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B, Behne S, Becker HJ (1989) Chronopharmacology of oral nifedipine in healthy subjects. Eur J Clin Pharmacol 36 Suppl:A 177

    Google Scholar 

  • Lemmer B (1991a) Circadian rhythms and drug delivery. J Control Release 16:63–74

    Article  CAS  Google Scholar 

  • Lemmer B (1991b) Implications of chronopharmacokinetics for drug delivery: antiasthmatics, H2-blockers and cardiovascular active drugs. Adv Drug Deliv Rev 6:83–100

    Article  CAS  Google Scholar 

  • Lemmer B (2005) Chronopharmacology and controlled drug release. Expert Opin Drug Deliv 2(4):667–681

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B (2006) The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmacol Ther 111(3):629–651

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B (2007a) Chronobiology and chronopharmacology of hypertension. In: White WB (ed) Clinical hypertension and vascular disease: blood pressure monitoring in cardiovascular medicine and therapeutics, 2nd edn. Humana Press, Totowa, pp 413–435

    Chapter  Google Scholar 

  • Lemmer B (2007b) Chronobiology and chronopharmacology of hypertension: importance of timing of dosing. In: White WB (ed) Blood pressure monitoring in cardiovascular medicine and therapeutics, 2nd edn. Humana Press, Totowa, pp 410–435

    Google Scholar 

  • Lemmer B (2007c) Hypertension: do we need to consider the biological clock in drug dosing? Expert Rev Cardiovasc Ther 5(3):375–379

    Article  PubMed  Google Scholar 

  • Lemmer B (2009) Discoveries of rhythms in human biological functions: a historical review. Chronobiol Int 26(6):1019–1068

    Article  PubMed  Google Scholar 

  • Lemmer B (2012a) Chronopharmakologie, 4th edn. Wiss. Verlagsges, Stuttgart

    Google Scholar 

  • Lemmer B (2012b) Masking effect of modern technology on annual rhythms: variation in births and deaths in a single family history over five centuries. Chronobiol Int 26:1019–1068

    Article  Google Scholar 

  • Lemmer B (2014) Seasonal variation in nativity and mortality and in socioeconomic conditions in a single family residing at different latitudes: Germany versus South Africa. ChronoPhysiol Ther 4:59–66

    Article  Google Scholar 

  • Lemmer B (2017) Signal transduction and chronopharmacology of regulation of circadian cardiovascular rhythms in animal models of human hypertension. Heart Fail Clin. https://doi.org/10.1016/j.hfc.2017.05.009

  • Lemmer B, Bruguerolle B (1994) Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet 26(6):419–427

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B, Nold G (1991) Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 32:627–629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lemmer B, Portaluppi F (1997) Chronopharmacology of cardiovascular diseases. In: Redfern PH, Lemmer B (eds) Physiology and pharmacology of biological rhythms, Handbook of experimental pharmacology, vol 125. Springer, Berlin, pp 251–297

    Chapter  Google Scholar 

  • Lemmer B, Nold G, Behne S, Becker HJ, Liefhold J, Kaiser R (1990) Chronopharmacology of oral nifedipine in healthy subjects and in hypertensive patients. Eur J Pharmacol 183:521

    Article  Google Scholar 

  • Lemmer B, Nold G, Behne S, Kaiser R (1991a) Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int 8(6):485–494

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B, Scheidel B, Blume H, Becker HJ (1991b) Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects. Eur J Clin Pharmacol 40:71–75

    Article  CAS  PubMed  Google Scholar 

  • Lemmer B, Middeke M, Schaaf B, Eckes L (2008) Prescribing practices and morning blood pressure control: results of a large-scale, primary-care study conducted in Germany. J Hum Hypertens 22(4):295–297

    Article  CAS  PubMed  Google Scholar 

  • Manfredini R et al (2012) Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol Int. https://doi.org/10.3109/07420528.2012.715843

  • Manfredini R, Salmi R, Cappadona R, Signani F, Basili S, Katsiki N (2017) Sex and circadian periodicity of cardiovascular diseases. Heart Fail Clin. https://doi.org/10.1016/j.hfc.2017.05.008

  • Moore JG (1989) Circadian rhythmicity in gastric emptying, acid secretion, and mucosal damage by drugs: implications for drug therapy. In: Lemmer B (ed) Chronopharmacology – biochemical and cellular interactions, Chronopharmacology – cellular and biochemical interactions. Marcel Dekker, New York, pp 631–654

    Google Scholar 

  • Nold G, Lemmer B (1998) Pharmacokinetics of sustained-release molsidomine after morning versus evening application in healthy subjects. Naunyn Schmiedebergs Arch Pharmacol 357:R173.

    Google Scholar 

  • Nold G, Strobel G, Lemmer B (1998) Morning versus evening amlodipine: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 3:17–25.

    CAS  PubMed  Google Scholar 

  • Pechere-Bertschi A et al (1998) Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 16:385–393

    Article  CAS  PubMed  Google Scholar 

  • Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y (1991) Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects a double-blind comparative study. Arterioscler Thromb 11(4):816–826

    Article  CAS  PubMed  Google Scholar 

  • Sanders SW, Moore JG, Buci KN, Bishop AL (1988) Circadian variation in the pharmacodynamic effects of intravenous ranitidine. Annu Rev Chronopharmacol 5:335–338

    Google Scholar 

  • Semenowicz-Siuda K, Markiewicz A, Korczynska-Wardecka J (1984) Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis. Int J Clin Pharmacol Ther Toxicol 22:653–658.

    CAS  PubMed  Google Scholar 

  • Scheidel B, Lemmer B (1991) Chronopharmacology of oral nitrates in healthy subjects. Chronobiol Int 8:409–419

    Article  CAS  PubMed  Google Scholar 

  • Smolensky MH, Hermida RC, Portaluppi F (2007a) Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol Int 24(1):171–181

    Article  CAS  PubMed  Google Scholar 

  • Smolensky MH, Lemmer B, Reinberg AE (2007b) Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 59(9–10):852–882

    Article  CAS  PubMed  Google Scholar 

  • Triscari J, Rossi L, Pan HY (1995) Chronokinetics of pravastatin administered in the PM compared with AM dosing. Am J Ther 2(4):265–268

    Article  PubMed  Google Scholar 

  • Uzu T, Kimura G (1999) Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 100(15):1635–1638

    Article  CAS  PubMed  Google Scholar 

  • Wallace A, Chinn D, Rubin G (2003) Taking simvastatin in the morning compared with in the evening: randomised controlled trial. BMJ 327(7418):788

    Article  PubMed  PubMed Central  Google Scholar 

  • Witte K et al (1993) Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54:177–186

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The author has no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Björn Lemmer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Lemmer, B. (2017). Chronopharmacology in Drug Development. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_40-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56637-5_40-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56637-5

  • Online ISBN: 978-3-319-56637-5

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics